These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10089307

  • 1. The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization.
    Baeyens KJ, De Bondt HL, Raeymaekers A, Fiers W, De Ranter CJ.
    Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):772-8. PubMed ID: 10089307
    [Abstract] [Full Text] [Related]

  • 2. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.
    Ameloot P, Fiers W, De Bleser P, Ware CF, Vandenabeele P, Brouckaert P.
    J Biol Chem; 2001 Oct 05; 276(40):37426-30. PubMed ID: 11448951
    [Abstract] [Full Text] [Related]

  • 3. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
    Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV.
    Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2830-4. PubMed ID: 1849278
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2.
    Reed C, Fu ZQ, Wu J, Xue YN, Harrison RW, Chen MJ, Weber IT.
    Protein Eng; 1997 Oct 01; 10(10):1101-7. PubMed ID: 9488135
    [Abstract] [Full Text] [Related]

  • 5. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y, Shibata H, Nakamura T, Yoshioka Y, Abe Y, Nomura T, Taniai M, Ohta T, Ikemizu S, Nakagawa S, Tsunoda S, Kamada H, Yamagata Y, Tsutsumi Y.
    J Mol Biol; 2009 Jan 30; 385(4):1221-9. PubMed ID: 19084540
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.
    Mancini F, Toro CM, Mabilia M, Giannangeli M, Pinza M, Milanese C.
    Biochem Pharmacol; 1999 Sep 01; 58(5):851-9. PubMed ID: 10449196
    [Abstract] [Full Text] [Related]

  • 7. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P, Takahashi N, Everaerdt B, Hostens J, Eugster HP, Fiers W, Brouckaert P.
    Eur J Immunol; 2002 Oct 01; 32(10):2759-65. PubMed ID: 12355427
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.
    Kim HM, Yu KS, Lee ME, Shin DR, Kim YS, Paik SG, Yoo OJ, Lee H, Lee JO.
    Nat Struct Biol; 2003 May 01; 10(5):342-8. PubMed ID: 12715002
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity studies of human tumour necrosis factors.
    Van Ostade X, Tavernier J, Fiers W.
    Protein Eng; 1994 Jan 01; 7(1):5-22. PubMed ID: 8140094
    [Abstract] [Full Text] [Related]

  • 10. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.
    Carter PH, Scherle PA, Muckelbauer JK, Voss ME, Liu RQ, Thompson LA, Tebben AJ, Solomon KA, Lo YC, Li Z, Strzemienski P, Yang G, Falahatpisheh N, Xu M, Wu Z, Farrow NA, Ramnarayan K, Wang J, Rideout D, Yalamoori V, Domaille P, Underwood DJ, Trzaskos JM, Friedman SM, Newton RC, Decicco CP.
    Proc Natl Acad Sci U S A; 2001 Oct 09; 98(21):11879-84. PubMed ID: 11592999
    [Abstract] [Full Text] [Related]

  • 11. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.
    Watts AD, Hunt NH, Wanigasekara Y, Bloomfield G, Wallach D, Roufogalis BD, Chaudhri G.
    EMBO J; 1999 Apr 15; 18(8):2119-26. PubMed ID: 10205166
    [Abstract] [Full Text] [Related]

  • 12. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
    Mongkolsapaya J, Grimes JM, Chen N, Xu XN, Stuart DI, Jones EY, Screaton GR.
    Nat Struct Biol; 1999 Nov 15; 6(11):1048-53. PubMed ID: 10542098
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome.
    Armstrong L, Thickett DR, Christie SJ, Kendall H, Millar AB.
    Am J Respir Cell Mol Biol; 2000 Jan 15; 22(1):68-74. PubMed ID: 10615067
    [Abstract] [Full Text] [Related]

  • 14. TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor.
    Wüest T, Gerlach E, Banerjee D, Gerspach J, Moosmayer D, Pfizenmaier K.
    Oncogene; 2002 Jun 20; 21(27):4257-65. PubMed ID: 12082613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-resolution crystal structure of arthropod Eiger TNF suggests a mode of receptor engagement and altered surface charge within endosomes.
    Bertinelli M, Paesen GC, Grimes JM, Renner M.
    Commun Biol; 2019 Jun 20; 2():293. PubMed ID: 31396573
    [Abstract] [Full Text] [Related]

  • 17. Structural basis of BLyS receptor recognition.
    Oren DA, Li Y, Volovik Y, Morris TS, Dharia C, Das K, Galperina O, Gentz R, Arnold E.
    Nat Struct Biol; 2002 Apr 20; 9(4):288-92. PubMed ID: 11862220
    [Abstract] [Full Text] [Related]

  • 18. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2.
    Fu ZQ, Harrison RW, Reed C, Wu J, Xue YN, Chen MJ, Weber IT.
    Protein Eng; 1995 Dec 20; 8(12):1233-41. PubMed ID: 8869635
    [Abstract] [Full Text] [Related]

  • 19. Exploring interaction of TNF and orthopoxviral CrmB protein by surface plasmon resonance and free energy calculation.
    Ivanisenko NV, Tregubchak TV, Saik OV, Ivanisenko VA, Shchelkunov SN.
    Protein Pept Lett; 2014 Dec 20; 21(12):1273-81. PubMed ID: 25101631
    [Abstract] [Full Text] [Related]

  • 20. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
    Shibata H, Yoshioka Y, Ikemizu S, Kobayashi K, Yamamoto Y, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Hayakawa T, Nagata S, Yamagata Y, Mayumi T, Kamada H, Tsutsumi Y.
    Clin Cancer Res; 2004 Dec 15; 10(24):8293-300. PubMed ID: 15623605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.